Objectives: Empirical evidence of discriminative validity is required to justify the use of mechanisms-based classifications of musculoskeletal pain in clinical practice. The purpose of this study was to evaluate the discriminative validity of mechanisms-based classifications of pain by identifying discriminatory clusters of clinical criteria predictive of "nociceptive," "peripheral neuropathic," and "central sensitization" pain in patients with low back (±leg) pain disorders.
M echanisms-based pain classification refers to the classification of pain based on assumptions as to the underlying neurophysiological mechanisms responsible for its generation and maintenance. 1, 2 Mechanisms-based classifications of pain have been advocated in clinical practice on the grounds that they may help explain observed variations in the nature and severity of many clinical presentations of musculoskeletal pain [eg, low back pain (LBP) disorders] (1) in which pain is reported in the absence of or disproportionate to any clearly identifiable pathology, (2) in which pain is reported to persist after the resolution of injury or pathology, (3) in which the severity of pain reported by patients with similar injuries and pathologies differs greatly, and paradoxically (4) in which pain does not exist despite evidence of injury or pathology. [3] [4] [5] In addition, it has been suggested that mechanismsbased approaches could improve the treatment of pain and optimize patients' outcomes by facilitating the selection of clinical interventions known or hypothesized to target the dominant underlying neurophysiological mechanisms responsible for its generation and maintenance. 6 Nociceptive pain (NP), peripheral neuropathic pain (PNP), and central sensitization pain (CSP) (ie, "central hyper-excitability"/"functional" pain) have been suggested as clinically meaningful mechanisms-based classifications of musculoskeletal pain, [7] [8] [9] [10] whereby each classification refers to a clinical presentation of pain assumed to reflect a dominance of nociceptive, peripheral neuropathic, or central pain mechanisms, respectively.
In the absence of a diagnostic gold standard, it has been hypothesized that mechanisms-based classifications of patients' pain may be undertaken clinically on the basis of patterns of symptoms and signs assumed to reflect its underlying neurophysiology. 11 In this regard, attempts have been made to develop a 3-category classification system for musculoskeletal pain. Using a judgemental approach toward classification system development, a Delphi survey was undertaken to generate expert, consensus-derived lists of clinical criteria associated with a dominance of "nociceptive," "peripheral neuropathic," and "central" mechanisms of musculoskeletal pain. 12 Empirical evidence of discriminative validity is required to justify the use of mechanisms-based classifications of musculoskeletal pain in clinical practice. 13 For the purpose of this study, discriminative validity was defined as the extent to which the categories of a classification system are able to differentiate between those with and without the disorder. 14 The discriminative validity of a classification system is supported if it can be shown that the presence or absence of specific clinical criteria can be used to differentiate between and predict membership of the categories that make up the classification system. To continue the development of mechanisms-based classifications of musculoskeletal pain, the aim of this study was to evaluate the discriminative validity of NP, PNP, and CSP as mechanisms-based classifications of pain in patients with low back (±leg) pain disorders by testing for and identifying a discriminatory cluster of clinical indicators associated with each category of pain.
MATERIALS AND METHODS

Study Design
This study was a cross-sectional, between-patients design using the validation by extreme-groups method. 14 
Setting
This discriminative validity study was carried out at 6 separate locations including 4 hospital sites, (1) 
Participants
Fifteen physiotherapists participated in data collection, including 13 public hospital-based clinicians, 1 of whom was the primary investigator (K.M.S.) and 2 private practitioners. All of the clinicians had specialized in general or specific fields of musculoskeletal physiotherapy. The mean number of years since qualification and spent working within the speciality of musculoskeletal physiotherapy was 12 (SD 5.2; range, 5 to 21) and 9.2 years (SD 4.38; range, 3 to 18), respectively. Thirteen clinicians possessed "masters" level qualifications in physiotherapy and 1 clinician had a postgraduate diploma.
Patients of 18 years of age or older referred with low back (±leg) pain were eligible for inclusion. Exclusion criteria included patients with a history of diabetes or central nervous system injury, pregnancy, or nonmusculoskeletal LBP. Patients were recruited from the outpatient waiting lists of each back pain screening clinic/physiotherapy service. All patients gave signed informed consent before their participation. A flowchart detailing patient recruitment is presented in Figure 1 .
Instrumentation and Procedures
Patient demographics were collected using a standardized form. Each patient was assessed using a standardized clinical interview and examination procedure based on accepted clinical practice. 15 During the clinical interview, patients were encouraged to disclose details of their LBP history, current symptomology, and its behavior. Patients were also screened for "red" and "yellow" flags associated with serious spinal pathology and psychosocial mediators, respectively in accordance with clinical practice guidelines. 16 The clinical examination included postural, movement, and neurological-based assessments. To complete the clinical criteria checklist (CCC), a number of additional symptoms (eg, spontaneous, paroxysmal pain, and dysesthesias) and signs (eg, allodynia, hyperalgesia, hyperpathia, and nerve palpation) were assessed.
After each patient examination, clinicians were required to complete a CCC consisting of 2 parts. "Part 1" required examiners to classify each patient's pain presentation. Patients were classified in to 1 of 3 categories of pain mechanism (ie, NP, PNP, CSP) or 1 of 4 possible "mixed" pain states derived from a combination of the original 3 categories (ie, Mixed: NP/PNP; Mixed: NP/CSP; Mixed: PNP/CSP; Mixed: NP/PNP/CSP) on the basis of experienced clinical judgement with regard to the likely dominant mechanisms assumed to underlie each patient's pain. Discriminative validity designs require the identification of the "extreme groups" (ie, pain type) and in the absence of a diagnostic gold standard the best alternative "reference standard"-defined as, "ythe best available method for establishing the presence or absence of a condition of interest," 17 may be expert clinical judgement. 14 "Under this assumption the development of classification criteria becomes an exercise in determining which history [and] physical examinationyfindings match the impression of an experienced clinician." 18 "Part 2" required examiners to complete a 38-item CCC, consisting of 26 symptoms and 12 signs (Table 1) , based on an expert consensus-derived list of clinical criteria assumed to reflect a dominance of NP, PNP, and CSP. 12 Response options for each criterion included "Present," "Absent," or "Don't know." To ensure that symptoms and signs were assessed consistently, clinicians were provided with practical training together with an "Assessment Manual" containing written instructions on how to undertake each patient examination, and interpret and document findings.
Sample Size Requirements
The minimum sample size required for this study was based on a recommended minimum of 10 patients per predictor variable. 19 The number of predictor variables evaluated in this study was 40, corresponding to the 38 items on the CCC plus the variables "age" and "sex," thus necessitating a minimum sample of 400 patients.
Data Analysis
Univariate analyses, using a w 2 test for independence, were carried out initially as a means of item reduction by identifying and excluding nondiscriminatory criteria. 19 Multivariate analyses using binary logistic regression (BLR) with Bayesian model averaging were then undertaken to test for and identify discriminatory clusters of Pain associated with and in proportion to trauma, a pathologic process or movement/postural dysfunction 3.
History of nerve injury, pathology, or mechanical compromise 4.
Pain disproportionate to the nature and extent of injury or pathology 5.
Usually intermittent and sharp with movement/mechanical provocation; may be a more constant dull ache or throb at rest 6.
More constant/unremitting pain 7.
Pain variously described as burning, shooting, sharp, or electric-shock-like 8.
Pain localized to the area of injury/dysfunction (with/without some somatic referral) 9.
Pain referred in a dermatomal or cutaneous distribution 10.
Widespread, nonanatomic distribution of pain 11.
Clear, proportionate mechanical/anatomic nature to aggravating and easing factors 12.
Mechanical pattern to aggravating and easing factors involving activities/postures associated with movement, loading, or compression of neural tissue 13.
Disproportionate, nonmechanical, unpredictable pattern of pain provocation in response to multiple/nonspecific aggravating/easing factors 14.
Reports of spontaneous (ie, stimulus-independent) pain and/or paroxysmal pain (ie, sudden recurrences and intensification of pain) 15.
Pain in association with other dysesthesias (eg, crawling, electrical, heaviness) 16.
Pain of high severity and irritability (ie, easily provoked, taking longer to settle) 17.
Pain in association with other symptoms of inflammation (ie, swelling, redness, heat) 18.
Pain in association with other neurological symptoms (eg, pins and needles, numbness, weakness) 19.
Night pain/disturbed sleep 20.
Responsive to simple analgesia/NSAIDs 21.
Less responsive to simple analgesia/NSAIDs and/or more responsive to antiepileptic (eg, Lyrica)/antidepression (eg, Amitriptyline) medication 22.
Usually rapidly resolving or resolving in accordance with expected tissue healing/pathology recovery times 23.
Pain persisting beyond expected tissue healing/pathology recovery times 24.
History of failed interventions (medical/surgical/therapeutic) 25.
Strong association with maladaptive psychosocial factors (eg, negative emotions, poor self-efficacy, maladaptive beliefs, and pain behaviors, altered family/work/social life, medical conflict) 26.
Pain in association with high levels of functional disability 27.
Antalgic (ie, pain relieving) postures/movement patterns 28.
Clear, consistent, and proportionate mechanical/anatomic pattern of pain reproduction on movement/mechanical testing of target tissues 29.
Pain/symptom provocation with mechanical/movement tests (eg, Active/Passive, Neurodynamic, ie, SLR) that move/load/ compress neural tissue 30.
Disproportionate, inconsistent, nonmechanical/nonanatomic pattern of pain provocation in response to movement/mechanical testing 31.
Positive neurological findings (altered reflexes, sensation, and muscle power in a dermatomal/myotomal or cutaneous nerve distribution) 32.
Localized pain on palpation 33.
Diffuse/nonanatomic areas of pain/tenderness on palpation 34.
Positive findings of allodynia within the distribution of pain 35.
Positive findings of hyperalgesia (primary and/or secondary) within the distribution of pain 36.
Positive findings of hyperpathia within the distribution of pain 37.
Pain/symptom provocation on palpation of relevant neural tissues 38.
Positive identification of various psychosocial factors (eg, catastrophization, fear-avoidance behavior, distress) symptoms and signs associated with a clinical classification of NP, PNP, and CSP. Three BLR models were evaluated, 1 for each category of pain. Modeling for each pain category, using NP versus non-NP as an example, was undertaken sequentially in the following way: 1. With NP as the designated "reference category," patients with NP were coded as "1" (equivalent to presence of the trait), and patients with non-NP (ie, those patients classified with a dominance of PNP and CSP) were coded as "0" (equivalent to "absence" of the trait). Clinical criteria were coded according to an identical interpretation (ie, "1"=present, "0"=absent). "Don't know" responses were treated as missing values. 2. Consensus-based Delphi-derived criteria associated with a dominance of NP were initially selected as candidate criteria for inclusion into the BLR model. 12 3. Additional clinical criteria with potential discriminative value were identified and included, when on the basis of a univariate analysis, the "absence" of specific criterion seemed to be associated with a dominance of NP. 4. Any criteria identified as "nondiscriminatory" from the univariate analyses were excluded. 5. All remaining candidate criteria were entered into the initial model, which was labeled as "Model 1." 6. Model parameters, for each criterion, were examined.
Criteria with a low "posterior probability" (eg, <5%) were identified and excluded. Remaining criteria were retained and reentered into a subsequent model ("Model 2"). 7. The posterior probabilities of each criterion were reevaluated. The criterion with the lowest "posterior probability" was identified and excluded. Remaining criteria were retained and reentered into a subsequent model ("Model 3"). 8. This process continued, with successive models labeled consecutively as "Model 4," "Model 5," and so on, until only criteria with a "posterior probability" of Z50% remained. These models were considered candidate "final models." The aim of each logistic regression was to produce an optimum model guided by considerations of classification accuracy and parsimony, that is to produce a discriminatory cluster of symptoms and signs for each category of pain, comprising the fewest clinical criteria while preserving classification accuracy. 19 Indices of classification accuracy [sensitivity, specificity, positive and negative predictive values, positive and negative likelihood ratios] with 2-sided 95% confidence intervals (CIs) were calculated to assess the classification accuracy of each final model. Univariate analyses were carried out using SPSS (SPSS for windows, version 15). Multivariate analyses were carried out in "R" (2009, version 2.9.2).
RESULTS
A convenience sample of 551 patients with musculoskeletal low back (±leg) pain disorders was invited to participate in this study. Fifty-one patients were ineligible according to the exclusion criteria, and 36 patients with a mixed (n=35) or indeterminate (n=1) pain state were excluded. Patient demographics for the final sample (n=464) are presented in Table 2 . 
Multivariate
Missing values were identified for 12 cases, thus reducing the valid sample size from n=464 to n=452 (NP n=252, PNP n=102, CSP n=98). Model parameters [regression coefficients and odds ratios (ORs) with 95% CI] for each criterion in the final NP, PNP, and CSP models are presented in Table 3 (where shortened criterion descriptions are given; full descriptions are presented in Table 1 ).
Cross tabulations from which the indices of classification accuracy were calculated for each final cluster are presented in Tables 4 to 6 . 20 Indices of classification accuracy, with 95% CIs, for each final model are presented in Table 7 .
Nociceptive
A dominance of NP was predicted by 7 criteria, including the presence of 3 symptoms (criteria 5, 8, 11), the "absence" of 3 symptoms (criteria 7, 15, 19), and 1 sign (criterion 27). According to the NP model, the strongest predictor of NP was criterion 8 (OR=69.79; 95% CI, 25. .81] suggesting that patients with "pain localized to the area of injury/dysfunction (with/without some somatic referral)" were over 69 times more likely to be classified with a dominance of NP compared with those with non-NP, controlling for all other variables in the model. The OR of 0.15 for criterion 15 was <1, indicating that patients with "pain in association with other A sensitivity of 90.9% indicates that this cluster of clinical criteria correctly predicted a dominance of NP in 90.9% of those patients classified with NP according to the reference standard of "experienced" clinical judgement, but incorrectly predicted 9.1% of these patients as having non-NP. The diagnostic OR of 100.67 indicates that that the cluster is 100 times more likely to accurately than inaccurately predict a dominance of NP in patients with a dominance of NP.
Peripheral Neuropathic
Three criteria (criteria 3, 9, 29) were found to be predictive of PNP. According to the final model, the strongest predictor was criterion 9 (OR=24.29; 95% CI, 6.33-93.18) suggesting that patients with "pain referred in a dermatomal or cutaneous distribution," were over 24 times more likely to be classified with a dominance of PNP than non-PNP, controlling for all other variables in the model.
A positive predictive value of 86.3% indicates that a patient with the cluster of clinical criteria outlined by the model is likely to have a dominance of PNP with an 86.3% level of probability. The negative predictive value indicates that the probability of a patient without the cluster having non-PNP is 96.0%.
Central Sensitization
A dominance of CSP was predicted by the presence of 3 symptoms (criteria 4, 13, 25) and 1 sign (criterion 33). The strongest predictor of CSP was criterion 13 (OR=30.69; 95% CI, 8.41-112.03) suggesting that patients with "disproportionate, nonmechanical, unpredictable pattern of pain provocation in response to multiple/nonspecific aggravating/easing factors," were over 30 times more likely to be classified with a dominance of CSP than non-CSP.
The LR+ of 40.64 suggests that the CSP cluster is over 40 times more likely to be found in a patient with a dominance of CSP than non-CP. The LR À indicates that the likelihood of the cluster being absent in patients with a dominance of CSP compared with non-CSP is 0.08. A summary of the mechanisms-based classification system for musculoskeletal pain based on the results of this study is presented in Figure 2 .
DISCUSSION
Using a statistical approach toward classification development, discriminatory clusters of symptoms and signs associated with a clinically determined dominance of NP, PNP, and CSP were identified from an original Delphiderived consensus of clinical indicators. In doing so, this study provides some preliminary discriminative validity evidence for NP, PNP, and CSP as mechanisms-based classifications of low back (±leg) pain.
A common mechanisms-based approach toward the classification of pain has been to dichotomize pain as being either predominantly "neuropathic" or "nociceptive," 11, 21, 22 and a number of screening instruments have been developed to facilitate this distinction clinically. 23 However, a fundamental attribute of any classification system is that its categories should be exhaustive, 24 meaning that all patients should be classifiable into one category. A dichotomized model of pain may be problematic for those patients hypothesized to have pain arising from or maintained by a dominance of dysfunctional central pain processes, whereby pain occurs or persists in the absence of, or disproportionate to, trauma/inflammation (ie, NP) or a peripheral nerve lesion (ie, PNP) 25 such as those with "fibromyalgia," whiplash-associated disorders, and some forms of chronic LBP. 9 A mechanisms-based classification system for pain comprising 3 categories may allow for the classification of broader populations of patients and be more useful clinically.
Although the classification system proposed in this study was comprised of three categories it is acknowledged that other "categories" of pain mechanisms may exist, such as "autonomic," "neuroendocrine," and "neuroimmune" pain. A number of investigators and mechanisms-based clinical reasoning strategies for pain have described the potential influence of autonomic, neuroendocrine, and neuroimmune mechanisms on pain transmission and modulation. [26] [27] [28] However, it has been suggested that activity from within these systems may not be so readily identifiable from clusters of symptoms and signs, and that they operate simultaneously and synergistically more as response and background systems in association with activity in the peripheral and central nervous systems. 10 Further elucidation of the role of these systems and the recognition of clinical markers may facilitate their inclusion into an expanded mechanisms-based classification system for pain.
A further consideration concerns the homogeneity of categorizations such as NP, PNP, and CSP, that is the extent to which patients classified with a given dominant pain state have pain attributable to common pathophysiological mechanisms. Categorical labels for constructs such as NP, PNP, and CSP, essentially describe and compartmentalize the highly complex and numerous pathophysiological processes associated with each construct together under a single umbrella term. For example, a patient with a dominance of NP could have pain secondary to inflammatory (tissue injury) or ischemic (tissue loading) mechanisms. 10 A patient with a dominance of PNP may have pain arising from the formation of "abnormal impulse generating sites," which may themselves be variously mechanosensitive, ischemic-sensitive, or chemo-sensitive, or from "cross-excitation" of injured axons from neighboring uninjured neurons. 29 And a patient with a dominance of CSP may have pain secondary to one or more of the following pathophysiological processes, such as "classic dorsal horn-mediated central sensitization," loss of spinal cord inhibitory interneurones, or forebrain-mediated descending facilitation. [30] [31] [32] The manner in which these different processes manifest, and the extent to which they may be identified and distinguished clinically is not known. Furthermore, neurobiological research currently allows for more mechanistic possibilities than can be distinguished clinically. 33 A more pragmatic perspective suggests that the validity and usefulness of any classification system is ultimately dependent on the extent to which it fulfills the purposes for which it was designed. 34 If categorical designations such as NP, PNP, and CSP can be shown to (1) help clinicians make sense of a patient's pain presentation, (2) facilitate an appropriate assessment, (3) predict an outcome (whether in response to natural history or treatment), and (4) facilitate the selection of appropriate interventions and/or discourage the selection of inappropriate ones, thus optimizing clinical outcomes and the use of healthcare resources, then arguably the classification system has fulfilled its function regardless of the extent to which its constituent categories can be said to exactly reflect homogenous pathophysiological mechanisms. Therefore, precise knowledge of the underlying pathophysiology of the disorder, although desirable to enhance the specificity of treatment selection, may not be an essential requirement for clinical validity. 35 Consistent with the findings of Scholz et al, 11 who developed a clinical tool for distinguishing neuropathic from non-neuropathic pain, the findings from this study suggest that relatively few symptoms and signs may be required to distinguish between pain types. Differentiating between the dominant mechanisms assumed to underlie -History of nerve injury, pathology or mechanical compromise.
-Pain referred in a dermatomal or cutaneous distribution.
-Pain/symptom provocation with mechanical/movement tests (i.e. active/passive,neurodynamic, e.g. Straight leg raise test) that move/load/compress neural tissue.
-Pain disproportionate to the nature and extent of injury or pathology.
-Disproportionate, non-mechanical, unpredictable pattern of pain provocation in response to multiple/non-specific aggravating/easing factors. -Strong association with maladaptive psychosocial factors (e.g. negative emotions, poor self-efficacy, maladaptive beliefs and pain behaviours, altered family/work/social life, medical conflict).
-Diffuse/non-anatomic areas of pain/tenderness on palpation.
patients' pain may be important clinically as it may have a direct impact on clinical decision making. 36 However, the predictive and prescriptive validity of mechanisms-based classifications of pain requires further empirical evaluation. The findings from this study should be interpreted in light of a number of methodological limitations.
In the absence of a "diagnostic" gold standard by which to determine mechanisms-based classifications of pain, patients were necessarily classified on the basis of a "reference standard" of "experienced" clinical judgement. 18 The robustness of the reference standard may have been improved if patients' pain had been classified on the basis of a unanimous agreement after independent assessments by 2 (or more clinicians). Validation by "extreme groups" on the basis of agreement by 2 clinicians (specialist pain consultants) has been used during the development and preliminary validation of a number of screening instruments designed for the purpose of identifying patients with neuropathic pain, such as the "painDETECT" 22 and "Douleur Neuropathique 4." 37 Other neuropathic screening instruments, however, such as the "ID-Pain," 38 "Neuropathic Pain Questionnaire," 39 and "Leeds Assessment of Neuropathic Symptoms and Signs," 40 have been developed on the basis of a single expert clinical judgement suggesting this could be an acceptable approach.
The assessment protocol used in this study required each clinician to both classify each patient's pain presentation and complete the CCC. This procedure could render the findings subject to a type of "clinical review bias," 41 whereby a clinician's preconceived ideas about the clinical criteria associated with each category of pain may have biased their responses during completion of the CCC. Ideally, the assignment of patients to each reference category and the completion of the CCC should be undertaken independently by 2 separate clinicians. In this way, the potential for a clinician's earlier classification to influence (ie, bias) their subsequent responses is eliminated. The resources available for this study did not allow for patient assessments by 2 clinicians.
Statistical approaches toward classification system development have inherent limitations. With logistic regression, the inclusion/exclusion of a criterion within a model can be dependent to some extent on statistical variation during the modeling process. 42 Therefore, any statistically derived model is characterized by a degree of uncertainty in that logistic regression will generate "a" model from a potential pool of other similar competing models. Determination of a "definitive" single model by means of logistic regression is, therefore, not possible. In light of this, regression modeling on a different data set from a different sample of patients would likely produce different, albeit similar, models (ie, clusters of clinical criteria) for each category of pain.
In addition, it has been shown that studies using logistic regression with small-to-moderate sample sizes tend to overestimate the OR of predictor variables as a consequence of a systematic mathematical bias inherent with logistic regression. 43 It is accepted that the sample included in this study may have led to inflated model estimates, and that a larger sample size with increased numbers of patients within each reference category may have produced more accurate estimates of model parameters and classification accuracy.
Development methodologies also tend to produce inflated estimates of model parameters and predictive accuracies because the model fitting process optimizes the model parameters to make the model fit the data as closely as possible. 42 It is this phenomenon that necessitates crossvalidation in an independent sample to obtain more accurate estimates of the "true" model parameters. As the methodology used in this study was developmental, it is likely that estimates concerning the relative contributions of criteria to each model (ie, regression coefficients and ORs) and the indices of classification accuracy (sensitivity, specificity etc) are inflated. Therefore, the values of these parameters should be interpreted with this caveat in mind.
The clusters of clinical criteria identified in this study were derived from a population of patients with LBP disorders. Evaluation of the same CCC on patient populations with other musculoskeletal disorders may have yielded different clusters. For example, it could be argued that the criterion, "pain in association with other symptoms of inflammation" was unlikely ever to be a potential predictor of NP because such symptoms (swelling, redness, heat), arguably, are rarely if ever identifiable in patients with LBP. However, it is possible that this criterion may have emerged as a significant predictor of NP in a patient population with ankle or knee injuries. Therefore, the clusters identified may not generalize to other musculoskeletal disorders.
By identifying a discriminatory cluster of symptoms and signs predictive of "nociceptive," "peripheral neuropathic," and "central sensitization" pain, this study provides some preliminary discriminative validity evidence for mechanisms-based classifications of musculoskeletal pain. Classification system validation requires the accumulation of validity evidence before their use in clinical practice can be recommended. As such, further studies are required to evaluate the construct and criterion validity of mechanisms-based classifications of musculoskeletal pain.
